MedPath

Comparing two new methods of providing anesthesia for patients undergoing operation without use of opioid medication.

Phase 3
Recruiting
Conditions
Brachial plexus disorders,
Registration Number
CTRI/2020/10/028305
Lead Sponsor
No sponsor
Brief Summary

In current anesthesia practice we use opioids as a crucial part to provide analgesia(pain relief) to the patient. Since ages we have known that opioids provide profound analgesia, yet they come with many side effects. This study is aimed to provide analgesia to the patients by non opioid medications, thereby excluding opioid side effects.  This study compares two methods of delivering anesthesia to patients undergoing surgery in general anaesthesia while avoiding opioids, and the pain profile of patients during and after the surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
60
Inclusion Criteria

Undergoing brachial plexus injury repair under general anesthesia ASA I or II.

Exclusion Criteria

High risk coronary or vascular disease Patient on beta blockers Hepatic dysfunction Eye globe injuries Increased intracranial pressure Increased intraocular pressure History of psychosis Uncontrolled hypertension.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Requirement of additional analgesic intraoperativelyBaseline and postoperatively
Secondary Outcome Measures
NameTimeMethod
Post-operative pain score15 min, 30 min, 1 hr, 2 hr, 4hr, 6 hr, 12 hr, 18 hr, 24hr
Time to first rescue analgesiaTime to first dose
Post operative sedation levelPost operative sedation level
Time to achieve modified Aldrete score 910 min, 20 min, 30 min, 40 min, 50 min, 60 min
Total analgesic requirement in first 24 hoursFirst 24 hours

Trial Locations

Locations (1)

PGIMER

🇮🇳

Chandigarh, CHANDIGARH, India

PGIMER
🇮🇳Chandigarh, CHANDIGARH, India
DR PRUDHVI RAJ
Principal investigator
9500918238
Prudhvipersonalmail@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.